Reports
Sale
Global Transcutaneous Pacing Market Share, Size, Growth, Trends, Analysis, Forecast: By Type: Single Chamber External Pacemaker, Dual Chamber External Pacemaker, Triple Chamber External Pacemaker; By Application: Bradycardia Treatment, Tachycardia Treatment, Others; By End Use; Regional Analysis; Competitive Landscape; 2024-2032
Global Transcutaneous Pacing Market Outlook
The global transcutaneous pacing market is expected to grow at a CAGR of 5.80% between 2024 and 2032, driven by the growing expansion of the healthcare sector across the emerging economies.
Key Trends in the Market
Transcutaneous pacing refers to a temporary method of pacing the heart of a patient during an emergency situation. This process involves transmission of electric current through the chest of a patient, leading to heart contraction. It is a readily available remedy which can be used in emergency situations.
- The global transcutaneous pacing market is being driven by the increasing prevalence of bradycardia, tachycardia, and cardiac arrhythmias. The increasing geriatric population is further leading to a shoot up in the cases of cardiovascular diseases, which is in turn bolstering the sale of transcutaneous pacemakers.
- The increasing awareness pertaining to the increase in heart-related disorders among the working adults is another crucial trend driving the transcutaneous pacing market growth. In addition, the stressful, hectic, and highly demanding lifestyles led by people worldwide is further enhancing the chances of cardiovascular diseases.
- The rising standards of hospitals and ambulatory surgical centres and the efforts being made to bolster the emergency care facilities are accelerating the demand for transcutaneous pacing.
Market Analysis
Based on type, the market can be segmented into single chamber external pacemaker, dual chamber external pacemaker, and triple chamber external pacemaker. On the basis of application, the market can be classified into bradycardia treatment and tachycardia treatment, among others. By end use, the market has been categorised into hospitals and specialty clinics, among others. The regional markets can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global transcutaneous pacing market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Medtronic Plc
- Biotronik
- OSCOR Inc.
- Others
Market Share by Application
The bradycardia treatment segment, based on application, accounts for a significant share in the transcutaneous pacing market. Bradycardia is one of the most prevalent conditions across the world, which leads to a dramatic decline of the rate of heart beat to 60 beats per minute. It can also be caused by complications in heart surgeries and heart tissue damage caused by ageing.
Transcutaneous pacing increases the heartbeat in a record time which boosts the comfort of the patient. The increasing cases of heart-related diseases owing to the rising geriatric population, sedentary lifestyles led by the working population, and lack of sleep, are some of the factors escalating the cases of bradycardia.
Market Share by Region
At a regional level, North America holds a decent share in the transcutaneous pacing market. The high quality of medical facilities available across the strong economies, such as the United States, is a crucial driving factor of the market. In addition, the increasing prevalence of obesity in the country is leading to an escalation in heart rhythm abnormalities.
Meanwhile, Europe holds a significant share in the market, which is being propelled by the advancements in healthcare infrastructure, increasing elderly population, and improving standards of living. Moreover, the presence of major medical manufacturers in the region are further providing impetus to the market for transcutaneous pacing.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Koninklijke Philips N.V. is a multinational conglomerate company which is headquartered in Amsterdam, Netherlands. It was founded in the year 1891 and has more than 78,000+ employees. Koninklijke Philips N.V. focusses on innovating in the field of health technology. Since its formation, the company has innovated a wide range of medical equipment.
Boston Scientific Corporation is one of the leading manufacturing companies based in the United States. This company manufactures high-end medical equipment which bolsters both the diagnostics and treatment infrastructure across healthcare units. Boston Scientific Corporation has around 40 offices worldwide and approximately 25,000 skilled workers.
Medtronic Plc is a prominent America medical technology company which is headquartered in Dublin, Ireland. The company was founded in 1949 and has a strength of 95,000+ employees. Medtronic Plc offers innovative healthcare solutions across the world. This organisation also focusses on insight-drive care.
Other market players include Biotronik, and OSCOR Inc., among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Industry Opportunities and Challenges
8 Global Transcutaneous Pacing Market Analysis
8.1 Key Industry Highlights
8.2 Global Transcutaneous Pacing Historical Market (2018-2023)
8.3 Global Transcutaneous Pacing Market Forecast (2024-2032)
8.4 Global Transcutaneous Pacing Market by Type
8.4.1 Single Chamber External Pacemaker
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Dual Chamber External Pacemaker
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Triple Chamber External Pacemaker
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.5 Global Transcutaneous Pacing Market by Application
8.5.1 Bradycardia Treatment
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Tachycardia Treatment
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Others
8.6 Global Transcutaneous Pacing Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Specialty Clinics
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Others
8.7 Global Transcutaneous Pacing Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Koninklijke Philips N.V.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Boston Scientific Corporation
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Medtronic Plc
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Biotronik
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 OSCOR Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Transcutaneous Pacing Market: Key Industry Highlights, 2017 and 2027
2. Global Transcutaneous Pacing Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global Transcutaneous Pacing Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global Transcutaneous Pacing Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Transcutaneous Pacing Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Transcutaneous Pacing Historical Market: Breakup by End Use (USD Million), 2018-2023
7. Global Transcutaneous Pacing Market Forecast: Breakup by End Use (USD Million), 2024-2032
8. Global Transcutaneous Pacing Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Transcutaneous Pacing Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Transcutaneous Pacing Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Transcutaneous Pacing Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Transcutaneous Pacing Market Structure.
Key Questions Answered in the Report
The market is estimated to grow at a CAGR of 5.80% in the forecast period of between 2024 and 2032.
The increasing prevalence of bradycardia and tachycardia, increasing healthcare expenditure across the emerging economies, and rising geriatric population are the major drivers of the market.
The key trends in the market include the growing research and development activities in the healthcare industry, favourable reimbursement policies of governments, and low cost setup for transcutaneous pacing.
Transcutaneous pacing is temporary and placed outside the heart, whereas pacemakers are long-term and implanted into the heart.
Hemodynamically unstable bradycardias and tachycardias require transcutaneous pacing.
A person with a heart rate of 60 beats per minute is considered as low, while a person using transcutaneous pacing has a heart rate of 71-79 beats per minute.
Heart rate of 120-140 with transcutaneous pacing is considered too high.
WiFi or any other signal transmission devices should be kept at least 15 cm away from the transcutaneous pacing equipment.
Koninklijke Philips N.V., Boston Scientific Corporation, Medtronic Plc, Biotronik, and OSCOR Inc., among others, are the key players in the transcutaneous pacing market, according to the report.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER